James J. L’italien, Ph.d.

Biography

    As Senior Vice President of Regulatory Affairs and Quality Assurance for InterMune Inc., Dr. L’Italien oversaw all global regulatory affairs and quality assurance activities in support of the company's commercial- and development-stage pharmaceutical programs—including the regulatory process for Esbriet®, which was granted a breakthrough designation by the FDA.As Vice President of Regulatory Affairs and Quality Assurance for the Geron Corporation, Dr. L’Italien supported development-stage programs in oncology and stem cell therapy.He served as Senior Vice President of Regulatory Affairs and Quality Assurance at Somaxon Pharmaceuticals, Inc.Dr. L’Italien also held the global position of Senior Vice President of Regulatory Affairs and Compliance at Ligand Pharmaceuticals, Inc. Dr. L’Italien earned a B.S. in chemistry from Merrimack College and his Ph.D. in protein biochemistry from Boston University.  

Research Interest